Clinical Trial Update: Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Diacerein for metabolic control in patients with Type 2 diabetes who have secondary failure to Metformin; the current sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Type 2 Diabetes Mellitus

Drugs mentioned

• Diacerein (Diacerein)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Diabetes-Related Complications, Diabetes Mellitus, Type 2 | Phase 2 | Status: UNKNOWN